+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

5-Alpha Reductase Deficiency Market Report 2025 - Product Thumbnail Image

5-Alpha Reductase Deficiency Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Ankylosing Spondylitis Market Report 2025 - Product Thumbnail Image

Ankylosing Spondylitis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Systemic Lupus Erythematosus Treatment Market Report 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bispecific Antibodies - Global Strategic Business Report - Product Thumbnail Image

Bispecific Antibodies - Global Strategic Business Report

  • Report
  • July 2025
  • 104 Pages
  • Global
From
From
From
Licensing Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1250 Pages
  • Global
From
From
From
Loading Indicator